The stock rallied 5.4% following results that demonstrated broad outperformance, driven by strong order intake and an upgraded full-year guidance reflecting solid growth in sales, earnings, and cash flow.
- Sales grew 9% on a constant currency basis in H1, with EBIT rising 11% and earnings per share up 13%.
- Order intake surged to GBP 16 billion for the half, pushing the order backlog to a record GBP 84 billion, providing strong revenue visibility.
- The company raised its full-year earnings per share guidance to 11%-13% growth and expects free cash flow to exceed GBP 2 billion.
- European sales grew 30%, outpacing the group overall, underpinned by accelerating defense budgets and strong demand for missile systems via MBDA.
- Cash generation remained robust with GBP 1.8 billion in free cash flow over the first six months, supporting strategic flexibility and shareholder returns.
Community Discussion